Landos Biopharma, Inc. – NASDAQ:LABP

Landos Biopharma stock price today

$22.91
-0.01
-0.09%
Financial Health
0
1
2
3
4
5
6
7
8
9

Landos Biopharma stock price monthly change

+6.65%
month

Landos Biopharma stock price quarterly change

+324.63%
quarter

Landos Biopharma stock price yearly change

+6869.60%
year

Landos Biopharma key metrics

Market Cap
71.67M
Enterprise value
N/A
P/E
-0.29
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
0.29
PEG ratio
-0.07
EPS
-3.98
Revenue
N/A
EBITDA
-25.20M
Income
-24.79M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Landos Biopharma stock price history

Landos Biopharma stock forecast

Landos Biopharma financial statements

Landos Biopharma, Inc. (NASDAQ:LABP): Profit margin
Jun 2023 0 -3.92M
Sep 2023 0 -5.86M
Dec 2023 0 -6.11M
Mar 2024 0 -8.89M
Landos Biopharma, Inc. (NASDAQ:LABP): Analyst Estimates
Mar 2024 0 -8.89M
Sep 2025 0 -2.85M
Oct 2025 0 -2.85M
Dec 2025 0 -3.10M
  • Analysts Price target

  • Financials & Ratios estimates

Landos Biopharma, Inc. (NASDAQ:LABP): Debt to assets
Jun 2023 46285000 3.01M 6.51%
Sep 2023 43230000 5.56M 12.88%
Dec 2023 38040000 6.24M 16.43%
Mar 2024 29896000 6.74M 22.55%
Landos Biopharma, Inc. (NASDAQ:LABP): Cash Flow
Jun 2023 -5.11M 3.97M -99K
Sep 2023 -2.22M 634K 0
Dec 2023 -4.96M 63K -1.83M
Mar 2024 -8.49M 0 0

Landos Biopharma alternative data

Landos Biopharma, Inc. (NASDAQ:LABP): Employee count
Aug 2023 22
Sep 2023 22
Oct 2023 22
Nov 2023 22
Dec 2023 22
Jan 2024 22
Feb 2024 22
Mar 2024 19
Apr 2024 19
May 2024 19
Jun 2024 19
Jul 2024 19

Landos Biopharma other data

0.74% -38.37%
of LABP is owned by hedge funds
297.86K -15.44M
shares is hold by hedge funds

Landos Biopharma, Inc. (NASDAQ:LABP): Insider trades (number of shares)
Period Buy Sel
Sep 2022 0 300000
Jan 2023 30909090 0
Feb 2023 0 786299
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 786,299 $1,888,814.77 $1,485,173,164,836
Purchase
PERCEPTIVE ADVISORS LLC 10 percent owner
Pre-funded Warrant 3,636,363 $0.01 $36,364
Purchase
PERCEPTIVE ADVISORS LLC 10 percent owner
Pre-funded Warrant 27,272,727 $0.01 $272,727
Sale
RTW INVESTMENTS, LP 10 percent owner
Common Stock 300,000 $0.69 $207,000
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 33,194 $4.75 $157,804
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 36,000 $4.84 $174,096
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 24,301 $5.11 $124,251
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 43,000 $5.02 $216,032
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 42,000 $5.1 $214,284
Sale
BASSAGANYA-RIERA JOSEP 10 percent owner
common stock 40,000 $5.37 $214,840
Patent
Application
Filling date: 20 May 2022 Issue date: 1 Sep 2022
Grant
Filling date: 2 Aug 2021 Issue date: 5 Jul 2022
Application
Filling date: 17 Nov 2021 Issue date: 19 May 2022
Application
Filling date: 2 Nov 2021 Issue date: 5 May 2022
Application
Filling date: 20 Oct 2021 Issue date: 28 Apr 2022
Application
Filling date: 20 Sep 2021 Issue date: 24 Mar 2022
Application
Filling date: 12 Nov 2021 Issue date: 10 Mar 2022
Application
Filling date: 29 Sep 2021 Issue date: 20 Jan 2022
Grant
Filling date: 16 Nov 2018 Issue date: 14 Dec 2021
Grant
Filling date: 25 Mar 2021 Issue date: 23 Nov 2021
Insider Compensation
Dr. Josep Bassaganya-Riera DVM, Ph.D. (1975) Advisor
$741,770
Ms. Jyoti Chauhan M.S. (1989) Executive Vice President of Clinical & Regulatory Affairs
$281,420
Dr. Raquel Hontecillas DVM, Ph.D. (1972) Chief Scientific Officer
$228,760
Thursday, 23 May 2024
prnewswire.com
Saturday, 11 May 2024
businesswire.com
Tuesday, 16 April 2024
prnewswire.com
Wednesday, 27 March 2024
businesswire.com
Tuesday, 26 March 2024
prnewswire.com
Monday, 25 March 2024
InvestorPlace
Reuters
Monday, 8 January 2024
GlobeNewsWire
Monday, 23 October 2023
GlobeNewsWire
Wednesday, 31 May 2023
GlobeNewsWire
Monday, 19 December 2022
PennyStocks
Wednesday, 11 May 2022
Zacks Investment Research
Monday, 15 November 2021
Seeking Alpha
Wednesday, 10 November 2021
Zacks Investment Research
Monday, 11 October 2021
GlobeNewsWire
Wednesday, 6 October 2021
GlobeNewsWire
Wednesday, 1 September 2021
GlobeNewsWire
Thursday, 26 August 2021
GlobeNewsWire
  • What's the price of Landos Biopharma stock today?

    One share of Landos Biopharma stock can currently be purchased for approximately $22.91.

  • When is Landos Biopharma's next earnings date?

    Unfortunately, Landos Biopharma's (LABP) next earnings date is currently unknown.

  • Does Landos Biopharma pay dividends?

    No, Landos Biopharma does not pay dividends.

  • How much money does Landos Biopharma make?

    Landos Biopharma has a market capitalization of 71.67M.

  • What is Landos Biopharma's stock symbol?

    Landos Biopharma, Inc. is traded on the NASDAQ under the ticker symbol "LABP".

  • What is Landos Biopharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Landos Biopharma?

    Shares of Landos Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Landos Biopharma's key executives?

    Landos Biopharma's management team includes the following people:

    • Dr. Josep Bassaganya-Riera DVM, Ph.D. Advisor(age: 50, pay: $741,770)
    • Ms. Jyoti Chauhan M.S. Executive Vice President of Clinical & Regulatory Affairs(age: 36, pay: $281,420)
    • Dr. Raquel Hontecillas DVM, Ph.D. Chief Scientific Officer(age: 53, pay: $228,760)
  • How many employees does Landos Biopharma have?

    As Jul 2024, Landos Biopharma employs 19 workers.

  • When Landos Biopharma went public?

    Landos Biopharma, Inc. is publicly traded company for more then 4 years since IPO on 4 Feb 2021.

  • What is Landos Biopharma's official website?

    The official website for Landos Biopharma is landosbiopharma.com.

  • Where are Landos Biopharma's headquarters?

    Landos Biopharma is headquartered at 1800 Kraft Drive, Blacksburg, VA.

  • How can i contact Landos Biopharma?

    Landos Biopharma's mailing address is 1800 Kraft Drive, Blacksburg, VA and company can be reached via phone at +54 02182232.

Landos Biopharma company profile:

Landos Biopharma, Inc.

landosbiopharma.com
Exchange:

NASDAQ

Full time employees:

19

Industry:

Biotechnology

Sector:

Healthcare

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therapeutic candidate that targets LANCL2 agonist for the treatment of systemic lupus erythematosus and rheumatoid arthritis (RA). Its preclinical candidates in development include LABP-66 is an oral and small molecule NOD-like pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA; LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; and LABP-111, an oral and small molecule LANCL2 pathway agonist for the treatment of nonalcoholic steatohepatitis and type 1 diabetes. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.

1800 Kraft Drive
Blacksburg, VA 24060

CIK: 0001785345
ISIN: US5150692011
CUSIP: 515069102